VA study of antipsychotic-related diabetes
Executive Summary
Department of Veteran's Affairs study "Antipsychotic Induced Diabetes in Veteran Schizophrenic Patients" will be submitted to the Journal of the American Medical Association for publication at the beginning of September (1"The Pink Sheet" April 21, 2003, p. 11). The study, scheduled to be presented at the International Conference on Therapeutic Risk in Philadelphia Aug. 24, found that Lilly's Zyprexa, Johnson & Johnson's Risperdal and AstraZeneca's Seroquel are associated with similar rates of metabolic complications...